Two single nucleotide polymorphisms in the von Hippel-Lindau tumor suppressor gene in Taiwanese with renal cell carcinoma

被引：10
作者：
Wang W.-C. [1 ]
Tsou M.-H. [2 ]
Chen H.-J. [3 ,4 ]
Hsu W.-F. [3 ]
Lai Y.-C. [3 ]
机构：
[1] Department of Obstetrics and Gynecology, Jen-Ai Hospital, Taichung
[2] Department of Pathology and Laboratory Medicine, Koo Foundation Sun Yat-Sen Cancer Center, Taipei
[3] School of Medical Laboratory and Biotechnology, Chung Shan Medical University, No.110, Chien Kuo N. Road, Taichung
[4] Department of Microbiology and Immunology, Chang Gung University, Taoyuan
来源：
BMC Research Notes | / 7卷 / 1期
关键词：
Loss of heterozygosity; Renal cell carcinoma; Single nucleotide polymorphism; Von Hippel-Lindau tumor suppressor gene;
D O I：
10.1186/1756-0500-7-638
中图分类号：
学科分类号：
摘要：
Background: Renal cell carcinoma, a common malignant tumor arising from the kidney, occurs in 3.62 and 1.95 cases per one hundred thousand people among men and women, respectively, in Taiwan each year. Approximately 80% of cases are classified as clear-cell renal cell carcinoma. Inactivation of the von Hippel-Lindau tumor suppressor gene has been implicated in the tumorigenic pathway of renal cell carcinoma. Two single nucleotide polymorphisms, rs779805 and rs1642742, located in the promoter and 3′ untranslated regions of the von Hippel-Lindau gene are informative and implicated in the occurrence of renal cell carcinoma worldwide. The aim of this study is to clarify whether these polymorphisms are associated with renal cell carcinoma in Taiwanese. Genomic DNA was isolated from normal and tumor tissues of 19 renal cell carcinoma patients. The samples were screened for allelic polymorphisms by restriction fragment length polymorphism with BsaJ I and Acc I digestion. Reconfirmation was carried out by direct sequencing.; Results: Consistent with Knudson's two-hit theory, AA to AG somatic mutations were observed in rs779805. In addition, loss of heterozygosity in both rs779805 and rs1642742 was demonstrated in 10 out of 15 RCC patients aged 50 or over. The G allele or AG heterozygote frequencies at these two loci were much higher in patient germline DNA when compared with the control group. After adjusting for age, the frequency of the G allele in both loci was much higher for late onset renal cell carcinoma in the Taiwanese population.; Conclusions: Our current results confirmed that the existence of G allele in both rs779805 and rs1642742 in the von Hippel-Lindau tumor suppressor gene is of importance in renal cell carcinoma tumorigenesis. However, more comprehensive and detailed research is needed to address the clinical relevance. Larger sample size is required to determine the exact power of correlation between these two genetic polymorphisms and renal cell carcinoma. © 2014 Wang et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 31 条
  • [1] Maher E.R., Bentley E., Yates J.R., Barton D., Jennings A., Fellows I.W., Ponder M.A., Ponder B.A., Benjamin C., Harris R., Ferguson-Smith M.A., Mapping of von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis, J Neurol Sci, 100, pp. 27-30, (1990)
  • [2] Wizigmann-Voos S., Plate K.H., Pathology, genetics and cell biology of hemangioblastomas, Histol Histopathol, 11, pp. 1049-1461, (1996)
  • [3] Tory K., Brauch H., Linehan M., Barba D., Oldfield E., Filling-Katz M., Seizinger B., Nakamura Y., White R., Marshall F.F., Lerman M.I., Zbar B., Specific genetic change in tumors associated with von Hippel-Lindau disease, J Natl Cancer Inst, 81, pp. 1097-1101, (1989)
  • [4] Yeung R.S., Xiao G.H., Jin F., Lee W.C., Testa J.R., Knudson A.G., Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene, Proc Natl Acad Sci U S A, 91, pp. 11413-11416, (1994)
  • [5] Berger A.H., Knudson A.G., Pandolfi P.P., A continuum model for tumour suppression, Nature, 476, pp. 163-169, (2011)
  • [6] Gnarra J.R., Tory K., Weng Y., Schmidt L., Wei M.H., Li H., Latif F., Liu S., Chen F., Duh F.M., Florence C., Pozzatti R., Walther M.M., Bander N.H., Grossman H.B., Brauch H., Pomer S., Brooks J.D., Isaacs W.B., Lerman M.I., Zbar B., Linehan W.M., Mutations of the VHL tumour suppressor gene in renal carcinoma, Nat Genet, 7, pp. 85-90, (1994)
  • [7] Latif F., Tory K., Gnarra J., Yao M., Duh F.M., Orcutt M.L., Stackhouse T., Kuzmin I., Modi W., Geil L., Schmidt L., Zhou F., Li H., Wei M.H., Chen F., Glenn G., Choyke P., Walther M.M., Weng Y., Duan D.R., Dean M., Glavac D., Richards F.M., Crossey P.A., Ferguson-Smith M.A., Paslier D.L., Chumakov I., Cohen D., Identification of the von Hippel-Lindau disease tumor suppressor gene, Science, 260, pp. 1317-1320, (1993)
  • [8] Crossey P.A., Richards F.M., Foster K., Green J.S., Prowse A., Latif F., Lerman M.I., Zbar B., Affara N.A., Ferguson-Smith M.A., Maher E.R., Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype, Hum Mol Genet, 3, pp. 1303-1308, (1994)
  • [9] Prowse A.H., Webster A.R., Richards F.M., Richard S., Olschwang S., Resche F., Affara N.A., Maher E.R., Somatic inactivation of the VHL gene in von Hippel-Lindau disease tumors, Am J Hum Genet, 60, pp. 765-771, (1997)
  • [10] Foster K., Prowse A., Van Den Berg A., Fleming S., Hulsbeek M.M., Crossey P.A., Richards F.M., Cairns P., Affara N.A., Ferguson-Smith M.A., Buys C., Maher E.R., Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma, Hum Mol Genet, 3, pp. 2169-2173, (1994)
1234